Biologics for PsA not Associated with Higher Heart Disease Risk
|
Study shows there is no substantial difference in cardiovascular risk associated with different biologic therapies for psoriasis and psoriatic arthritis patients.
|
Read more
|
|
CV Risk in Rheumatic Diseases: 3 New Things
|
(1) Inflammatory diseases raise risk of venous thromboembolism; (2) antiphospholipid antibodies play a role in MI; (3) persistent hyperuricemia
|
Read more
|
|
High Disease Activity in RA: A Danger Zone for Heart Disease and Infection
|
Good management of rheumatoid arthritis may also prevent serious infection, myocardial infarction, and even death related to comorbid disease.
|
Read more
|
|